{
    "Trade/Device Name(s)": [
        "Macro & Micro-Test HCG Pregnancy Test Midstream"
    ],
    "Submitter Information": "Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.",
    "510(k) Number": "K230741",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150063"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "October 13, 2023",
    "Summary Letter Received Date": "August 31, 2023",
    "Submission Date": "August 17, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Immunochromatography"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Macro & Micro-Test HCG Pregnancy Test Midstream, an over-the-counter qualitative lateral flow immunoassay for urine detection of hCG to aid early pregnancy detection.",
    "Indications for Use Summary": "Intended for over-the-counter use for qualitative detection of hCG hormone in urine to aid early detection of pregnancy.",
    "fda_folder": "Clinical Chemistry"
}